1263205-96-4 Usage
Uses
Used in Pharmaceutical Industry:
3-[[3,5-bis(trifluoroMethyl)phenyl]aMino]-4-[[(1S,2S)-2-(diMethylaMino)cyclohexyl]aMino]-Cyclobutene-1,2-dione is used as a potential pharmaceutical compound for its unique structure and potential biological activity. Its electron-withdrawing trifluoromethylphenyl group and amine functionalities may contribute to its interaction with biological targets, warranting further research and testing to explore its therapeutic potential.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-[[3,5-bis(trifluoroMethyl)phenyl]aMino]-4-[[(1S,2S)-2-(diMethylaMino)cyclohexyl]aMino]-Cyclobutene-1,2-dione serves as a promising molecular scaffold for the development of new drugs. Its complex structure allows for various modifications to optimize its pharmacological properties, such as potency, selectivity, and bioavailability. Further research is necessary to fully understand its properties and potential uses in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1263205-96-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,3,2,0 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1263205-96:
(9*1)+(8*2)+(7*6)+(6*3)+(5*2)+(4*0)+(3*5)+(2*9)+(1*6)=134
134 % 10 = 4
So 1263205-96-4 is a valid CAS Registry Number.
1263205-96-4Relevant academic research and scientific papers
Massolo, Elisabetta,Benaglia, Maurizio,Genoni, Andrea,Annunziata, Rita,Celentano, Giuseppe,Gaggero, Nicoletta
, p. 5591 - 5596 (2015)
An efficient organocatalytic methodology has been developed to perform the stereoselective addition of 2-carboxythioesters-1,3-dithiane to nitroalkenes. Under mild reaction conditions γ-nitro-β-aryl-α-keto esters with up to 92% ee were obtained, realizing a formal catalytic stereoselective conjugate addition of the glyoxylate anion synthon. The reaction products are versatile starting materials for further synthetic transformations; for example, the simultaneous reduction of the nitro group and removal of the dithiane ring was accomplished, allowing the preparation of a GABAB receptor agonist baclofen.
